We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 793 results
  1. Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration

    Early pathological features of frontotemporal lobar degeneration (FTLD) due to MAPT pathogenic variants (FTLD-MAPT) are understudied, since...

    Lucia AA Giannini, Merel O Mol, ... Harro Seelaar in Acta Neuropathologica Communications
    Article Open access 02 August 2023
  2. Increase in wasteosomes (corpora amylacea) in frontotemporal lobar degeneration with specific detection of tau, TDP-43 and FUS pathology

    Wasteosomes (or corpora amylacea) are polyglucosan bodies that appear in the human brain with aging and in some neurodegenerative diseases, and have...

    Raquel Alsina, Marta Riba, ... Jordi Vilaplana in Acta Neuropathologica Communications
    Article Open access 15 June 2024
  3. Association of cortical and subcortical microstructure with disease severity: impact on cognitive decline and language impairments in frontotemporal lobar degeneration

    Background

    Cortical and subcortical microstructural modifications are critical to understanding the pathogenic changes in frontotemporal lobar...

    Wencai Ding, Peng Ren, ... Maria Luisa Mandelli in Alzheimer's Research & Therapy
    Article Open access 21 March 2023
  4. Plasma biomarkers increase diagnostic confidence in patients with Alzheimer’s disease or frontotemporal lobar degeneration

    Background

    The recent development of techniques to assess plasma biomarkers has changed the way the research community envisions the future of...

    Daniele Altomare, Ilenia Libri, ... Barbara Borroni in Alzheimer's Research & Therapy
    Article Open access 11 May 2024
  5. Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration

    Background

    In the last decade, non-invasive blood-based and neurophysiological biomarkers have shown great potential for the discrimination of several...

    Alberto Benussi, Valentina Cantoni, ... Barbara Borroni in Alzheimer's Research & Therapy
    Article Open access 13 October 2022
  6. YKL-40 changes are not detected in post-mortem brain of patients with Alzheimer’s disease and frontotemporal lobar degeneration

    Background

    YKL-40 (Chitinase 3-like I) is increased in CSF of Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD) patients and is...

    Yanaika S. Hok-A-Hin, Jeroen J. M. Hoozemans, ... Marta del Campo in Alzheimer's Research & Therapy
    Article Open access 25 July 2022
  7. Intracortical diffusion tensor imaging signature of microstructural changes in frontotemporal lobar degeneration

    Background

    Frontotemporal lobar degeneration (FTLD) is a neuropathological construct with multiple clinical presentations, including the behavioural...

    Mario Torso, Gerard R. Ridgway, ... Steven Chance in Alzheimer's Research & Therapy
    Article Open access 22 October 2021
  8. Lack of a protective effect of the Tmem106b “protective SNP” in the Grn knockout mouse model for frontotemporal lobar degeneration

    Genetic variants in TMEM106B are a common risk factor for frontotemporal lobar degeneration and the most important modifier of disease risk in...

    Anne-Sophie Cabron, Uwe Borgmeyer, ... Markus Damme in Acta Neuropathologica Communications
    Article Open access 27 January 2023
  9. White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer’s disease

    Background

    We aimed to systematically describe the burden and distribution of white matter hyperintensities (WMH) and investigate correlations with...

    Philippe Desmarais, Andrew F. Gao, ... Mario Masellis in Alzheimer's Research & Therapy
    Article Open access 13 July 2021
  10. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration

    Background

    Synapse degeneration is an early event in pathological frontotemporal lobar degeneration (FTLD). Consequently, a surrogate marker of...

    Alba Cervantes González, David J. Irwin, ... Olivia Belbin in Molecular Neurodegeneration
    Article Open access 08 April 2022
  11. Clusters of co-abundant proteins in the brain cortex associated with fronto-temporal lobar degeneration

    Background

    Frontotemporal lobar degeneration (FTLD) is characterized pathologically by neuronal and glial inclusions of hyperphosphorylated tau or by...

    Claire Bridel, Juami H. M. van Gils, ... Charlotte E. Teunissen in Alzheimer's Research & Therapy
    Article Open access 23 March 2023
  12. Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors

    Movement disorders (MD) have been linked to degeneration of the substantia nigra (SN) in Parkinson’s disease and include bradykinesia, rigidity, and...

    Luigi Fiondella, Priya Gami-Patel, ... Anke A. Dijkstra in Acta Neuropathologica Communications
    Article Open access 12 April 2023
  13. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology

    Frontotemporal lobar degeneration proteinopathies with tau inclusions (FTLD-Tau) or TDP-43 inclusions (FTLD-TDP) are associated with clinically...

    Lucia A. A. Giannini, Claire Peterson, ... David J. Irwin in Acta Neuropathologica Communications
    Article Open access 23 February 2021
  14. Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance

    Frontotemporal lobar degeneration with TPD-43-immunoreactive pathology (FTLD-TDP) is subclassified based on the type and cortical laminar...
    Manuela Neumann, Edward B. Lee, Ian R. Mackenzie in Frontotemporal Dementias
    Chapter 2021
  15. Neuroimaging in Frontotemporal Lobar Degeneration: Research and Clinical Utility

    Frontotemporal lobar dementia (FTLD) is a clinically and pathologically complex disease. Advances in neuroimaging techniques have provided a...
    Sheena I. Dev, Bradford C. Dickerson, Alexandra Touroutoglou in Frontotemporal Dementias
    Chapter 2021
  16. Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies

    Frontotemporal lobar degeneration (FTLD) is a group of disorders characterized by degeneration of the frontal and temporal lobes, leading to...

    Shunsuke Koga, Aya Murakami, ... Dennis W. Dickson in Acta Neuropathologica Communications
    Article Open access 06 July 2023
  17. Evidence of cerebellar TDP-43 loss of function in FTLD-TDP

    Frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) is a neurodegenerative disease primarily affecting the frontal and/or temporal...

    Sarah Pickles, Tania F. Gendron, ... Mercedes Prudencio in Acta Neuropathologica Communications
    Article Open access 25 July 2022
  18. Processing of progranulin into granulins involves multiple lysosomal proteases and is affected in frontotemporal lobar degeneration

    Background

    Progranulin loss-of-function mutations are linked to frontotemporal lobar degeneration with TDP-43 positive inclusions (FTLD-TDP- Pgrn )....

    Swetha Mohan, Paul J. Sampognaro, ... Aimee W. Kao in Molecular Neurodegeneration
    Article Open access 03 August 2021
  19. Fluid Biomarkers of Frontotemporal Lobar Degeneration

    A timely diagnosis of frontotemporal degeneration (FTD) is frequently challenging due to the heterogeneous symptomatology and poor...
    Emma L. van der Ende, John C. van Swieten in Frontotemporal Dementias
    Chapter 2021
  20. Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations

    Loss of function progranulin ( GRN ) mutations are a major autosomal dominant cause of frontotemporal dementia (FTD). Patients with FTD due to GRN ...

    Skylar E. Davis, Anna K. Cook, ... Andrew E. Arrant in Acta Neuropathologica Communications
    Article Open access 28 April 2023
Did you find what you were looking for? Share feedback.